Zydus Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2025
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed the exchanges about its 30th Annual General Meeting scheduled for Tuesday, August 12, 2025, at 10:00 a.m. IST, to be held via video conferencing. Along with the AGM notice, the company is filing its maiden Integrated Annual Report for FY 2024-25, covering the year ended March 31, 2025. Key financial highlights disclosed include total revenue from operations up 19% year-on-year to Rs. 232.4 billion, EBITDA up 31% to Rs. 70,585 million with margin expansion of 290 bps to 30.4%, and adjusted net profit up 23% to Rs. 47,451 million. The company maintained a net cash position of Rs. 48,836 million and reported a Net debt to equity ratio of -0.20. The cut-off date for dividend eligibility is July 25, 2025, with payment expected on or after August 14, 2025, and the e-voting window runs from August 9 to August 11, 2025.
This is a routine compliance filing, but it confirms strong FY25 performance with healthy growth, expanding margins, and a debt-free balance sheet. Shareholders should note the July 25, 2025 record date for final dividend eligibility and the August 12 AGM where resolutions including the appointment of new secretarial auditors will be put to vote.